Nancy Lapid

(Reuters) – The following summarizes recent research on COVID-19. These include studies that need further investigation to confirm the results and those that are yet to receive peer review certification.

Multiple myeloma patients are receiving vaccines less than anticipated

Coronavirus vaccines have been shown to be less effective in protecting people who are affected by multiple myeloma. This is evident from Colin Powell (ex-Secretary of State), who succumbed to COVID-19 complications on Monday. A new study has shed light on multiple myeloma patient’s vulnerability to coronavirus. The study, expected to appear online on Monday in Cancer Cell https://www.cell.com/cancer-cell/home, reveals these patients not only produce fewer neutralizing antibodies in response to the vaccines, but also have a weak response from the immune system’s T cells. The antibodies fight the virus in its natural environment, but T cells are more effective at attacking infected cells. The study included 44 multiple myeloma patients who received two doses of the mRNA vaccine from Pfizer/BioNTech. Moderna (NASDAQ:) Those with low to no antibodies to COVID-19’s mRNA had either few or none of the T cells necessary to prevent severe COVID-19 infections. In a statement, Dr. Samir Parekh, a study leader at the Icahn school of medicine at Mount Sinai, New York City said that “the unexpected lack of T cells responses and the absence of antibodies after SARS-CoV-2 vaccine is of concern.” According to the researchers, the results highlight the necessity for blood tests in order to determine the immune response of these patients following vaccination.

The claims of stem cell therapies for COVID-19, however, are absurd

Researchers found that many businesses made false and unsubstantiated claims regarding supposed stem cells to cure COVID-19. They published their findings in Stem Cell reports https:// on Thursday. According to the authors, it is not clear how many companies are selling or manufacturing these fake products to consumers. Only some diseases and conditions are currently treated using stem cells. For the prevention or treatment of COVID-19, no such therapy has been approved for approval by any government regulator. Advertising falsely claims that their treatments’ safety and effectiveness are supported with evidence. According to the authors, “The spreading of misinformation could cause serious harm to public safety and health.”

Click for a Reuters graphic https://tmsnrt.rs/3c7R3Bl on vaccines in development.